Sales of Leqembi® totaled 29.3 billion yen in the second quarter 2026

EarningsLeqembiPositive

AI Analysis

Summary

BioArctic partner Eisai reported Leqembi Q2 2026 global sales of 29.3 billion yen. The revenue figures were published in conjunction with Biogen's quarterly earnings report.

Financial Highlights

Revenue

29.3 billion yen

Outcome Details

Q2 2026 sales revenue reported

Importance:5/10

Sentiment:

0.60

RevenueEarningsLeqembiQ2 2026Commercialization

Related Companies

$BIOA-B.ST $ESALY $BIIB

Read the original article

Published by PR Newswire Clinical Trials on July 29, 2026 10:27 AM

Read Original